Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance

Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance

Item
http://www.wikidata.org/entity/Q33388870
Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment optionsA computational approach to analyze the mechanism of action of the kinase inhibitor bafetinibA target-disease network model of second-generation BCR-ABL inhibitor action in Ph+ ALLResults of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamideA neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomasNeuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model.Monitoring response and resistance to treatment in chronic myeloid leukemia.Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy.Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspectiveSrc family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses.Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia.B-lymphocyte lineage cells and the respiratory system.Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells.Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy.
P2860

Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leukemias after imatinib resistance or intolerance

Item
http://www.wikidata.org/entity/Q33388870
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@ast
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@en
type
label
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@ast
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@en
prefLabel
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@ast
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Phase 1 study of INNO-406, a d ...... inib resistance or intolerance
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932